No abstract available
MeSH terms
-
Cardiovascular Diseases / blood
-
Cardiovascular Diseases / etiology
-
Cardiovascular Diseases / prevention & control
-
Cholesterol, HDL / blood
-
Cholesterol, LDL / blood
-
Combined Modality Therapy
-
Drugs, Investigational / therapeutic use
-
Fatty Acids, Omega-3 / therapeutic use
-
Fibric Acids / adverse effects
-
Fibric Acids / therapeutic use
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Hypercholesterolemia / blood
-
Hypercholesterolemia / drug therapy
-
Hyperlipidemias / blood
-
Hyperlipidemias / drug therapy*
-
Hypertriglyceridemia / blood
-
Hypertriglyceridemia / drug therapy
-
Hypolipidemic Agents / adverse effects
-
Hypolipidemic Agents / therapeutic use*
-
Lipoprotein(a) / blood
-
Reference Values
-
Risk Factors
-
Treatment Outcome
-
Triglycerides / blood
Substances
-
Cholesterol, HDL
-
Cholesterol, LDL
-
Drugs, Investigational
-
Fatty Acids, Omega-3
-
Fibric Acids
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Hypolipidemic Agents
-
Lipoprotein(a)
-
Triglycerides